Valiant Laboratories IPO will open for subscription from 27 September 2023. The company aims for an issue size of ₹152.46 Cr through this IPO.
Company Overview
| Full name | Valiant Laboratories Limited |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Company Website | https://valiantlabs.in/ |
About Company
Incorporation in 2021, Valiant Laboratories is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company focusing on the manufacturing of Paracetamol. Bulk drugs/APIs serve as raw materials for manufacturing finished dosage forms or formulations. Valiant Laboratories manufacturing facility is located at Palghar, in the state of Maharashtra, India which is spread over an aggregate parcel of land admeasuring about 2,000 sq. mts. with an aggregate annual total installed capacity of 9,000 MT per annum.
For the financial year ended 31 March 2023, 2022, and 2021, the revenue from sales outside India contributed 0.39%, 0.60 %, and 0.33 %, respectively of the total revenue from operations. The revenue from operations grew at a CAGR of 23.90% between FY 2017 and FY 2023. The restated profit after tax, grew at a CAGR of 26.81% between FY 2017 and FY 2023.
The Objectives of the Issue
- Investment in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).
- Investment in VASPL for funding its working capital requirements.
- General corporate purposes.
IPO Timetable
| IPO Opening date | 27 September 2023 |
| IPO Closing | 03 October 2023 |
| Basis of Allotment | 06 October 2023 |
| Initiation Refund | 09 October 2023 |
| Credit to Demat Account | 10 October 2023 |
| Listing Date | 11 October 2023 |
IPO details
| Issue type | Book Built Issue IPO |
| IPO issue size | ₹152.46 Cr – 10,890,000 shares |
| Fresh Issue | ₹152.46 Cr – 10,890,000 shares |
| Offer for sale | Nil |
| Face value | ₹10 per share |
| Price Band Offer Price | ₹133 to ₹140 per share |
| Lot size | 105 Shares |
| Shareholding pre-issue | 32,560,000 |
| Shareholding post-issue | 44,116,000 |
| Listing Exchange | BSE & NSE |
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 105 | ₹14,700 |
| Retail (Max) | 13 | 1365 | ₹191,100 |
| S-HNI (Min) | 14 | 1,470 | ₹205,800 |
| S-HNI (Max) | 68 | 7,140 | ₹999,600 |
| B-HNI (Min) | 69 | 7,245 | ₹1,014,300 |
Reservation Details
| QIB Shares Offered | 50% |
| NII (HNI) Shares Offered | 15% |
| Retail Shares Offered | 35% |
Financial Performance
| FY 2021 | FY 2022 | FY 2023 | |
| Revenue | 82.38 | 209.14 | 333.91 |
| Expenses | 72.04 | 179.73 | 300.64 |
| Net income | 4.75 | 22.59 | 29.03 |
| Margin (%) | 5.77 | 10.80 | 8.69 |
Valuations & Margins
| FY 2021 | FY 2022 | FY 2023 | |
| EPS | 10.83 | 9.52 | 8.91 |
| PE ratio | – | – | – |
| RONW (%) | 34.54 | 38.48 | 28.86 |
| NAV | – | – | 30.86 |
| ROCE (%) | 70.86 | 35.75 | 22.76 |
| EBITDA (%) | 27.42 | 14.52 | 10.51 |
| Debt/Equity | 0.00 | 0.85 | 0.59 |
Company Promoters
- Shantilal Shivji Vora
- Dhanvallabh Ventures LLP (DVL)
Promoter Holding
| Pre Issue Share Holding | 100% |
| Post Issue Share Holding | 74.94% |
Lead Manager(s)
UNISTONE CAPITAL PRIVATE LIMITED
A/305, Dynasty Business Park, Andheri Kurla Road,
Andheri East, Mumbai 400059, Maharashtra
Phone:+91 98200 57533
Email: mb@unistonecapital.com
Website: www.unistonecapital.com
IPO Registrar
LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park
L.B.S. Marg, Vikhroli West
Mumbai – 400 083, Maharashtra
Phone: +91 22 4918 6200
Email: valiantlaboratories.ipo@linkintime.co.in
Website: www.linkintime.co.in
Contact Details
VALIANT LABORATORIES LIMITED
104, Udyog Kshetra, Mulund Goregaon Link Road,
Mulund West, Mumbai- 400080, Maharashtra
Phone: +91-22-4971 2001
Email: complianceofficer@valiantlabs.in
Website: www.valiantlabs.in
Allotment Status
Valiant Laboratories IPO allotment will be available on Link Intime’s website. Click on this link to get allotment status.
Final thoughts
Valiant Laboratories IPO is going to hit Dalal Street soon. applying for an IPO is purely a personal choice. study well about the company and subscribe if you are feeling good about the company. I hope this post will give you enough details to make a fundamental study of the company. learn well and make wise decisions.
Happy Investing
